Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Absci Corporation - Common Stock (NQ:ABSI)

4.430 +0.150 (+3.50%)
Streaming Delayed Price Updated: 12:32 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Absci Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Absci Appoints Biopharma Leader Mary Szela to Board of Directors
Former Abbott executive who led the US launch and global expansion of Humira® adds three decades of commercial and clinical leadership expertise 
From Absci Corporation
Via GlobeNewswire
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Assessing Absci: Insights From 6 Financial Analysts
 
Via Benzinga
Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Peering Into Absci's Recent Short Interest
 
Via Benzinga
Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease
From Absci Corporation
Via GlobeNewswire
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025
From Absci Corporation
Via GlobeNewswire
Earnings Scheduled For May 13, 2025
 
Via Benzinga
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods. 
Via Benzinga
Topics Animal Testing
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
 
Via Benzinga
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements
Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing... 
Via Benzinga
Topics Animal Testing
Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
 
Via Benzinga
Which Healthcare Stock Is the Best Buy Right Now?
Healthcare stocks provide a combination of upstarts with a high risk, high reward proposition to established firms that can be a defensive maneuver. 
Via MarketBeat
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV. 
Via Benzinga
Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
A Glimpse Into The Expert Outlook On Absci Through 7 Analysts
 
Via Benzinga
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Earnings Scheduled For March 18, 2025
 
Via Benzinga
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip
Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX. 
Via Benzinga
Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025
From Absci Corporation
Via GlobeNewswire
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the KeyBanc Capital Markets Healthcare Forum
From Absci Corporation
Via GlobeNewswire
Absci to Participate in the TD Cowen 45th Annual Health Care Conference
From Absci Corporation
Via GlobeNewswire
What's going on in today's after hours session
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales
 
Via Benzinga
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and $9 price target. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.